K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Peter Valent
also known as Anna Porwit, P VALENT, P Valent
Medical University of Vienna · Slovak University of Technology in Bratislava · Çanakkale Onsekiz Mart Üniversitesi · University of Iowa
About this author
Works
1,476
Cited by
72,366
h-index
131
i10
826
ORCID ↗
Top papers
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg, Heinz Tuechler, Julie Schanz, et al.
·
2012
·
Blood
↗ 3,113
OA
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Johannes Zuber, Junwei Shi, Eric Wang, et al.
·
2011
·
Nature
↗ 1,864
Diagnostic criteria and classification of mastocytosis: a consensus proposal
Peter Valent, Hans‐P. Horny, Luís Escribano, et al.
·
2001
·
Leukemia Research
↗ 1,108
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elsa Bernard, Heinz Tuechler, Peter L. Greenberg, et al.
·
2022
·
NEJM Evidence
↗ 788
OA
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
Detlef Haase, Ulrich Germing, Julie Schanz, et al.
·
2007
·
Blood
↗ 785
OA
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes
Peter Valent, Amy D. Klion, Hans‐Peter Horny, et al.
·
2012
·
Journal of Allergy and Clinical Immunology
↗ 755
OA
Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria
Peter Valent, Cem Akin, Luís Escribano, et al.
·
2007
·
European Journal of Clinical Investigation
↗ 744
Cancer stem cell definitions and terminology: the devil is in the details
Peter Valent, Dominique Bonnet, Ruggero De Maria, et al.
·
2012
·
Nature reviews. Cancer
↗ 688
OA
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Julie Schanz, Heinz Tüchler, Françesc Solé, et al.
·
2012
·
Journal of Clinical Oncology
↗ 688
OA
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent, Cem Akin, Dean D. Metcalfe
·
2016
·
Blood
↗ 670
OA
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets
Uwe Rix, Oliver Hantschel, Gerhard Dürnberger, et al.
·
2007
·
Blood
↗ 659
OA
Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals
Rudolf Valenta, Michael Duchêne, K. Pettenburger, et al.
·
1991
·
Science
↗ 642